Baliopharm AG
CytImmune Sciences Inc
Eyevensys SAS
G&E Corp
GlaxoSmithKline Plc
Inflamalps SA
Inmune Bio Inc
Philogen SpA
Promethera Biosciences SA
Published | Pages | Publisher | Report code |
---|---|---|---|
Mar 2019 | 61 | Global Markets Direct | ASDR-483922 |
Baliopharm AG
CytImmune Sciences Inc
Eyevensys SAS
G&E Corp
GlaxoSmithKline Plc
Inflamalps SA
Inmune Bio Inc
Philogen SpA
Promethera Biosciences SA